Delta Air Lines Inc. (DE) (DAL) Falls 3.57% for February 08

Equities Staff |

One of the S&P 500’s big losers for Monday February 08 was Delta Air Lines Inc. (DE) (DAL). The company’s stock fell 3.57% to $40.51 on volume of 10.47 million shares.

The stock opened the day at 41.31 and traded between a low of $40.05 and a high of $41.60. The stock finished the day down $1.5 per share. Delta Air Lines Inc. (DE) has an average daily volume of 9.74 million and a total float of 786.47 million shares. The 50-day SMA for Delta Air Lines Inc. (DE) is $47.95 and its 200-day SMA is $46.02. The high for the stock over the last 52 weeks is $52.77 and the low is $34.61.

Delta Air Lines Inc provides scheduled air transportation for passengers and cargo throughout the United States and around the world. The Company's business segments are airline and refinery.

Delta Air Lines Inc. (DE) is centered in Atlanta, GA, and has 83,000 employees. Today’s trading day leaves the company with a market cap of $31.86 billion. The company has a P/S ratio of n/a, P/B ratio of 3.08, and a 7.6.

For a complete fundamental analysis analysis of Delta Air Lines Inc. (DE), check out Equities.com’s Stock Valuation Analysis report for DAL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…